nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A7—Tamoxifen—pancreatic cancer	0.0705	0.102	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0705	0.102	CbGbCtD
Zaleplon—CYP3A7—Irinotecan—pancreatic cancer	0.0541	0.0783	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0541	0.0783	CbGbCtD
Zaleplon—CYP3A5—Tamoxifen—pancreatic cancer	0.0529	0.0765	CbGbCtD
Zaleplon—CYP3A5—Erlotinib—pancreatic cancer	0.045	0.0651	CbGbCtD
Zaleplon—CYP3A5—Irinotecan—pancreatic cancer	0.0406	0.0588	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0397	0.0574	CbGbCtD
Zaleplon—CYP3A7—Docetaxel—pancreatic cancer	0.0397	0.0574	CbGbCtD
Zaleplon—CYP3A7—Sunitinib—pancreatic cancer	0.0395	0.0571	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0395	0.0571	CbGbCtD
Zaleplon—CYP3A5—Docetaxel—pancreatic cancer	0.0298	0.0431	CbGbCtD
Zaleplon—CYP3A5—Sunitinib—pancreatic cancer	0.0296	0.0429	CbGbCtD
Zaleplon—CYP3A4—Tamoxifen—pancreatic cancer	0.0206	0.0298	CbGbCtD
Zaleplon—CYP3A4—Erlotinib—pancreatic cancer	0.0175	0.0254	CbGbCtD
Zaleplon—CYP3A4—Irinotecan—pancreatic cancer	0.0158	0.0229	CbGbCtD
Zaleplon—CYP3A4—Docetaxel—pancreatic cancer	0.0116	0.0168	CbGbCtD
Zaleplon—CYP3A4—Sunitinib—pancreatic cancer	0.0116	0.0167	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—pancreatic cancer	0.00865	0.0125	CbGbCtD
Zaleplon—Mood swings—Doxorubicin—pancreatic cancer	0.000198	0.00064	CcSEcCtD
Zaleplon—Dysgeusia—Docetaxel—pancreatic cancer	0.000197	0.000639	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000197	0.000637	CcSEcCtD
Zaleplon—Ataxia—Doxorubicin—pancreatic cancer	0.000196	0.000636	CcSEcCtD
Zaleplon—Feeling abnormal—Irinotecan—pancreatic cancer	0.000196	0.000635	CcSEcCtD
Zaleplon—Asthma—Epirubicin—pancreatic cancer	0.000195	0.000631	CcSEcCtD
Zaleplon—Dysphagia—Epirubicin—pancreatic cancer	0.000195	0.000631	CcSEcCtD
Zaleplon—Back pain—Docetaxel—pancreatic cancer	0.000195	0.000631	CcSEcCtD
Zaleplon—Pain—Fluorouracil—pancreatic cancer	0.000195	0.000631	CcSEcCtD
Zaleplon—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000194	0.00063	CcSEcCtD
Zaleplon—Eosinophilia—Epirubicin—pancreatic cancer	0.000193	0.000625	CcSEcCtD
Zaleplon—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000193	0.000624	CcSEcCtD
Zaleplon—Dry skin—Doxorubicin—pancreatic cancer	0.000191	0.00062	CcSEcCtD
Zaleplon—Dizziness—Sunitinib—pancreatic cancer	0.000191	0.000618	CcSEcCtD
Zaleplon—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000191	0.000618	CcSEcCtD
Zaleplon—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000191	0.000617	CcSEcCtD
Zaleplon—Angina pectoris—Epirubicin—pancreatic cancer	0.00019	0.000615	CcSEcCtD
Zaleplon—Breast disorder—Doxorubicin—pancreatic cancer	0.000189	0.000611	CcSEcCtD
Zaleplon—Abdominal pain—Irinotecan—pancreatic cancer	0.000188	0.000609	CcSEcCtD
Zaleplon—Body temperature increased—Irinotecan—pancreatic cancer	0.000188	0.000609	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000188	0.000609	CcSEcCtD
Zaleplon—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000188	0.000608	CcSEcCtD
Zaleplon—Bronchitis—Epirubicin—pancreatic cancer	0.000187	0.000607	CcSEcCtD
Zaleplon—Anaemia—Docetaxel—pancreatic cancer	0.000186	0.000603	CcSEcCtD
Zaleplon—Gastritis—Doxorubicin—pancreatic cancer	0.000185	0.000598	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000184	0.000596	CcSEcCtD
Zaleplon—Muscular weakness—Doxorubicin—pancreatic cancer	0.000184	0.000596	CcSEcCtD
Zaleplon—Body temperature increased—Gemcitabine—pancreatic cancer	0.000183	0.000593	CcSEcCtD
Zaleplon—Dysuria—Epirubicin—pancreatic cancer	0.000182	0.00059	CcSEcCtD
Zaleplon—Rash—Sunitinib—pancreatic cancer	0.000182	0.000589	CcSEcCtD
Zaleplon—Dermatitis—Sunitinib—pancreatic cancer	0.000182	0.000589	CcSEcCtD
Zaleplon—Urticaria—Fluorouracil—pancreatic cancer	0.000181	0.000586	CcSEcCtD
Zaleplon—Headache—Sunitinib—pancreatic cancer	0.000181	0.000586	CcSEcCtD
Zaleplon—Syncope—Docetaxel—pancreatic cancer	0.000181	0.000585	CcSEcCtD
Zaleplon—Asthma—Doxorubicin—pancreatic cancer	0.00018	0.000584	CcSEcCtD
Zaleplon—Dysphagia—Doxorubicin—pancreatic cancer	0.00018	0.000584	CcSEcCtD
Zaleplon—Pollakiuria—Epirubicin—pancreatic cancer	0.00018	0.000583	CcSEcCtD
Zaleplon—Body temperature increased—Fluorouracil—pancreatic cancer	0.00018	0.000583	CcSEcCtD
Zaleplon—Eosinophilia—Doxorubicin—pancreatic cancer	0.000179	0.000578	CcSEcCtD
Zaleplon—Palpitations—Docetaxel—pancreatic cancer	0.000178	0.000576	CcSEcCtD
Zaleplon—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000178	0.000576	CcSEcCtD
Zaleplon—Weight increased—Epirubicin—pancreatic cancer	0.000177	0.000575	CcSEcCtD
Zaleplon—Loss of consciousness—Docetaxel—pancreatic cancer	0.000177	0.000573	CcSEcCtD
Zaleplon—Weight decreased—Epirubicin—pancreatic cancer	0.000176	0.000571	CcSEcCtD
Zaleplon—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000176	0.00057	CcSEcCtD
Zaleplon—Angina pectoris—Doxorubicin—pancreatic cancer	0.000176	0.000569	CcSEcCtD
Zaleplon—Pneumonia—Epirubicin—pancreatic cancer	0.000175	0.000566	CcSEcCtD
Zaleplon—Hypertension—Docetaxel—pancreatic cancer	0.000174	0.000563	CcSEcCtD
Zaleplon—Bronchitis—Doxorubicin—pancreatic cancer	0.000173	0.000562	CcSEcCtD
Zaleplon—Chest pain—Docetaxel—pancreatic cancer	0.000171	0.000555	CcSEcCtD
Zaleplon—Arthralgia—Docetaxel—pancreatic cancer	0.000171	0.000555	CcSEcCtD
Zaleplon—Myalgia—Docetaxel—pancreatic cancer	0.000171	0.000555	CcSEcCtD
Zaleplon—Nausea—Sunitinib—pancreatic cancer	0.000171	0.000555	CcSEcCtD
Zaleplon—Asthenia—Irinotecan—pancreatic cancer	0.000171	0.000553	CcSEcCtD
Zaleplon—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00017	0.000552	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00017	0.000551	CcSEcCtD
Zaleplon—Stomatitis—Epirubicin—pancreatic cancer	0.000169	0.000549	CcSEcCtD
Zaleplon—Conjunctivitis—Epirubicin—pancreatic cancer	0.000169	0.000547	CcSEcCtD
Zaleplon—Dysuria—Doxorubicin—pancreatic cancer	0.000169	0.000546	CcSEcCtD
Zaleplon—Dry mouth—Docetaxel—pancreatic cancer	0.000168	0.000543	CcSEcCtD
Zaleplon—Sweating—Epirubicin—pancreatic cancer	0.000167	0.00054	CcSEcCtD
Zaleplon—Pollakiuria—Doxorubicin—pancreatic cancer	0.000167	0.00054	CcSEcCtD
Zaleplon—Asthenia—Gemcitabine—pancreatic cancer	0.000166	0.000538	CcSEcCtD
Zaleplon—Haematuria—Epirubicin—pancreatic cancer	0.000166	0.000537	CcSEcCtD
Zaleplon—Confusional state—Docetaxel—pancreatic cancer	0.000166	0.000537	CcSEcCtD
Zaleplon—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000165	0.000533	CcSEcCtD
Zaleplon—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000164	0.000532	CcSEcCtD
Zaleplon—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000164	0.000532	CcSEcCtD
Zaleplon—Oedema—Docetaxel—pancreatic cancer	0.000164	0.000532	CcSEcCtD
Zaleplon—Weight increased—Doxorubicin—pancreatic cancer	0.000164	0.000532	CcSEcCtD
Zaleplon—Epistaxis—Epirubicin—pancreatic cancer	0.000164	0.000531	CcSEcCtD
Zaleplon—Pruritus—Gemcitabine—pancreatic cancer	0.000164	0.000531	CcSEcCtD
Zaleplon—Weight decreased—Doxorubicin—pancreatic cancer	0.000163	0.000529	CcSEcCtD
Zaleplon—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000163	0.000527	CcSEcCtD
Zaleplon—Pneumonia—Doxorubicin—pancreatic cancer	0.000162	0.000524	CcSEcCtD
Zaleplon—Shock—Docetaxel—pancreatic cancer	0.000162	0.000524	CcSEcCtD
Zaleplon—Nervous system disorder—Docetaxel—pancreatic cancer	0.000161	0.000522	CcSEcCtD
Zaleplon—Pruritus—Fluorouracil—pancreatic cancer	0.000161	0.000522	CcSEcCtD
Zaleplon—Tachycardia—Docetaxel—pancreatic cancer	0.00016	0.00052	CcSEcCtD
Zaleplon—Skin disorder—Docetaxel—pancreatic cancer	0.00016	0.000517	CcSEcCtD
Zaleplon—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000158	0.000511	CcSEcCtD
Zaleplon—Dizziness—Irinotecan—pancreatic cancer	0.000157	0.000509	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—pancreatic cancer	0.000157	0.000508	CcSEcCtD
Zaleplon—Anorexia—Docetaxel—pancreatic cancer	0.000157	0.000507	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000156	0.000506	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000155	0.000503	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—pancreatic cancer	0.000154	0.000499	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—pancreatic cancer	0.000154	0.000498	CcSEcCtD
Zaleplon—Hypotension—Docetaxel—pancreatic cancer	0.000154	0.000497	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—pancreatic cancer	0.000153	0.000497	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000152	0.000493	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—pancreatic cancer	0.000152	0.000491	CcSEcCtD
Zaleplon—Dizziness—Fluorouracil—pancreatic cancer	0.000151	0.000488	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—pancreatic cancer	0.00015	0.000487	CcSEcCtD
Zaleplon—Rash—Irinotecan—pancreatic cancer	0.00015	0.000486	CcSEcCtD
Zaleplon—Dermatitis—Irinotecan—pancreatic cancer	0.00015	0.000485	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00015	0.000485	CcSEcCtD
Zaleplon—Headache—Irinotecan—pancreatic cancer	0.000149	0.000482	CcSEcCtD
Zaleplon—Insomnia—Docetaxel—pancreatic cancer	0.000149	0.000481	CcSEcCtD
Zaleplon—Paraesthesia—Docetaxel—pancreatic cancer	0.000148	0.000478	CcSEcCtD
Zaleplon—Dyspnoea—Docetaxel—pancreatic cancer	0.000147	0.000475	CcSEcCtD
Zaleplon—Somnolence—Docetaxel—pancreatic cancer	0.000146	0.000473	CcSEcCtD
Zaleplon—Rash—Gemcitabine—pancreatic cancer	0.000146	0.000473	CcSEcCtD
Zaleplon—Dermatitis—Gemcitabine—pancreatic cancer	0.000146	0.000473	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—pancreatic cancer	0.000146	0.000472	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—pancreatic cancer	0.000145	0.000471	CcSEcCtD
Zaleplon—Headache—Gemcitabine—pancreatic cancer	0.000145	0.00047	CcSEcCtD
Zaleplon—Dyspepsia—Docetaxel—pancreatic cancer	0.000145	0.000469	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000144	0.000465	CcSEcCtD
Zaleplon—Rash—Fluorouracil—pancreatic cancer	0.000144	0.000465	CcSEcCtD
Zaleplon—Dermatitis—Fluorouracil—pancreatic cancer	0.000143	0.000465	CcSEcCtD
Zaleplon—Decreased appetite—Docetaxel—pancreatic cancer	0.000143	0.000463	CcSEcCtD
Zaleplon—Headache—Fluorouracil—pancreatic cancer	0.000143	0.000462	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000142	0.000461	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000142	0.00046	CcSEcCtD
Zaleplon—Nausea—Irinotecan—pancreatic cancer	0.000141	0.000457	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—pancreatic cancer	0.000141	0.000456	CcSEcCtD
Zaleplon—Pain—Docetaxel—pancreatic cancer	0.000141	0.000455	CcSEcCtD
Zaleplon—Constipation—Docetaxel—pancreatic cancer	0.000141	0.000455	CcSEcCtD
Zaleplon—Chills—Epirubicin—pancreatic cancer	0.00014	0.000453	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—pancreatic cancer	0.000139	0.000451	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—pancreatic cancer	0.000138	0.000447	CcSEcCtD
Zaleplon—Nausea—Gemcitabine—pancreatic cancer	0.000138	0.000446	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—pancreatic cancer	0.000137	0.000443	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—pancreatic cancer	0.000136	0.00044	CcSEcCtD
Zaleplon—Feeling abnormal—Docetaxel—pancreatic cancer	0.000135	0.000439	CcSEcCtD
Zaleplon—Nausea—Fluorouracil—pancreatic cancer	0.000135	0.000438	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—pancreatic cancer	0.000135	0.000437	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—pancreatic cancer	0.000135	0.000436	CcSEcCtD
Zaleplon—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000134	0.000435	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—pancreatic cancer	0.000134	0.000434	CcSEcCtD
Zaleplon—Tension—Epirubicin—pancreatic cancer	0.000133	0.000432	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—pancreatic cancer	0.000133	0.000431	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—pancreatic cancer	0.000132	0.000427	CcSEcCtD
Zaleplon—Back pain—Epirubicin—pancreatic cancer	0.000131	0.000426	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—pancreatic cancer	0.00013	0.000422	CcSEcCtD
Zaleplon—Abdominal pain—Docetaxel—pancreatic cancer	0.00013	0.000421	CcSEcCtD
Zaleplon—Body temperature increased—Docetaxel—pancreatic cancer	0.00013	0.000421	CcSEcCtD
Zaleplon—Chills—Doxorubicin—pancreatic cancer	0.00013	0.00042	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—pancreatic cancer	0.000128	0.000413	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—pancreatic cancer	0.000126	0.00041	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000126	0.000408	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—pancreatic cancer	0.000126	0.000407	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—pancreatic cancer	0.000126	0.000407	CcSEcCtD
Zaleplon—Agitation—Epirubicin—pancreatic cancer	0.000125	0.000404	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—pancreatic cancer	0.000124	0.000401	CcSEcCtD
Zaleplon—Tension—Doxorubicin—pancreatic cancer	0.000123	0.000399	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—pancreatic cancer	0.000123	0.000399	CcSEcCtD
Zaleplon—Malaise—Epirubicin—pancreatic cancer	0.000122	0.000397	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—pancreatic cancer	0.000122	0.000395	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—pancreatic cancer	0.000122	0.000395	CcSEcCtD
Zaleplon—Syncope—Epirubicin—pancreatic cancer	0.000122	0.000395	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—pancreatic cancer	0.000122	0.000394	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—pancreatic cancer	0.00012	0.000389	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—pancreatic cancer	0.000119	0.000387	CcSEcCtD
Zaleplon—Asthenia—Docetaxel—pancreatic cancer	0.000118	0.000382	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—pancreatic cancer	0.000117	0.00038	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000117	0.000378	CcSEcCtD
Zaleplon—Pruritus—Docetaxel—pancreatic cancer	0.000116	0.000377	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—pancreatic cancer	0.000116	0.000376	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—pancreatic cancer	0.000116	0.000375	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—pancreatic cancer	0.000116	0.000375	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—pancreatic cancer	0.000116	0.000375	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—pancreatic cancer	0.000116	0.000374	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—pancreatic cancer	0.000115	0.000373	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000115	0.000372	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—pancreatic cancer	0.000114	0.00037	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—pancreatic cancer	0.000113	0.000367	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—pancreatic cancer	0.000113	0.000366	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—pancreatic cancer	0.000113	0.000366	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—pancreatic cancer	0.000113	0.000365	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—pancreatic cancer	0.000112	0.000362	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—pancreatic cancer	0.000111	0.00036	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000111	0.000359	CcSEcCtD
Zaleplon—Oedema—Epirubicin—pancreatic cancer	0.000111	0.000359	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00011	0.000358	CcSEcCtD
Zaleplon—Shock—Epirubicin—pancreatic cancer	0.000109	0.000353	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—pancreatic cancer	0.000109	0.000352	CcSEcCtD
Zaleplon—Dizziness—Docetaxel—pancreatic cancer	0.000109	0.000352	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—pancreatic cancer	0.000109	0.000351	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—pancreatic cancer	0.000108	0.00035	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—pancreatic cancer	0.000108	0.000349	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000107	0.000347	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—pancreatic cancer	0.000107	0.000347	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—pancreatic cancer	0.000107	0.000347	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—pancreatic cancer	0.000107	0.000347	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—pancreatic cancer	0.000107	0.000345	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000106	0.000344	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—pancreatic cancer	0.000106	0.000342	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—pancreatic cancer	0.000106	0.000342	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—pancreatic cancer	0.000105	0.000339	CcSEcCtD
Zaleplon—Rash—Docetaxel—pancreatic cancer	0.000104	0.000336	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—pancreatic cancer	0.000104	0.000336	CcSEcCtD
Zaleplon—Dermatitis—Docetaxel—pancreatic cancer	0.000104	0.000335	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—pancreatic cancer	0.000103	0.000335	CcSEcCtD
Zaleplon—Headache—Docetaxel—pancreatic cancer	0.000103	0.000333	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—pancreatic cancer	0.000103	0.000332	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000103	0.000332	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000101	0.000327	CcSEcCtD
Zaleplon—Shock—Doxorubicin—pancreatic cancer	0.000101	0.000327	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000101	0.000326	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—pancreatic cancer	0.0001	0.000325	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—pancreatic cancer	0.0001	0.000324	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—pancreatic cancer	9.96e-05	0.000323	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—pancreatic cancer	9.96e-05	0.000322	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—pancreatic cancer	9.92e-05	0.000321	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—pancreatic cancer	9.88e-05	0.00032	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—pancreatic cancer	9.86e-05	0.000319	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—pancreatic cancer	9.78e-05	0.000317	CcSEcCtD
Zaleplon—Nausea—Docetaxel—pancreatic cancer	9.76e-05	0.000316	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—pancreatic cancer	9.76e-05	0.000316	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—pancreatic cancer	9.64e-05	0.000312	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—pancreatic cancer	9.59e-05	0.00031	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.57e-05	0.00031	CcSEcCtD
Zaleplon—Constipation—Epirubicin—pancreatic cancer	9.48e-05	0.000307	CcSEcCtD
Zaleplon—Pain—Epirubicin—pancreatic cancer	9.48e-05	0.000307	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.35e-05	0.000303	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—pancreatic cancer	9.28e-05	0.0003	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—pancreatic cancer	9.21e-05	0.000298	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—pancreatic cancer	9.15e-05	0.000296	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—pancreatic cancer	9.14e-05	0.000296	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—pancreatic cancer	9.12e-05	0.000295	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.07e-05	0.000294	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—pancreatic cancer	9.03e-05	0.000292	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—pancreatic cancer	8.92e-05	0.000289	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.86e-05	0.000287	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—pancreatic cancer	8.81e-05	0.000285	CcSEcCtD
Zaleplon—Pain—Doxorubicin—pancreatic cancer	8.77e-05	0.000284	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—pancreatic cancer	8.77e-05	0.000284	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—pancreatic cancer	8.76e-05	0.000284	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—pancreatic cancer	8.76e-05	0.000284	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—pancreatic cancer	8.45e-05	0.000274	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.39e-05	0.000272	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—pancreatic cancer	8.15e-05	0.000264	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—pancreatic cancer	8.11e-05	0.000263	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—pancreatic cancer	8.11e-05	0.000263	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—pancreatic cancer	7.95e-05	0.000258	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—pancreatic cancer	7.84e-05	0.000254	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—pancreatic cancer	7.36e-05	0.000238	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—pancreatic cancer	7.33e-05	0.000237	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—pancreatic cancer	7.26e-05	0.000235	CcSEcCtD
Zaleplon—Rash—Epirubicin—pancreatic cancer	6.99e-05	0.000226	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—pancreatic cancer	6.98e-05	0.000226	CcSEcCtD
Zaleplon—Headache—Epirubicin—pancreatic cancer	6.95e-05	0.000225	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—pancreatic cancer	6.78e-05	0.00022	CcSEcCtD
Zaleplon—Nausea—Epirubicin—pancreatic cancer	6.59e-05	0.000213	CcSEcCtD
Zaleplon—Rash—Doxorubicin—pancreatic cancer	6.47e-05	0.000209	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—pancreatic cancer	6.46e-05	0.000209	CcSEcCtD
Zaleplon—Headache—Doxorubicin—pancreatic cancer	6.43e-05	0.000208	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—pancreatic cancer	6.09e-05	0.000197	CcSEcCtD
